The pharmacologic management of obesity.
作者信息
Cerda J J
机构信息
Division of Gastroenterology, Hepatology, University of Florida College of Medicine, USA.
出版信息
J Fla Med Assoc. 1997 Feb;84(2):89-92.
PMID:9066231
Abstract
摘要
相似文献
1
The pharmacologic management of obesity.肥胖的药物治疗
J Fla Med Assoc. 1997 Feb;84(2):89-92.
2
Pharmacologic therapies for obesity.肥胖的药物治疗。
Gastroenterol Clin North Am. 2010 Mar;39(1):69-79. doi: 10.1016/j.gtc.2010.01.001.
3
Phentermine, topiramate and their combination for the treatment of adiposopathy ('sick fat') and metabolic disease.苯丁胺、托吡酯及其联合用药治疗脂肪代谢障碍（“病态肥胖”）和代谢性疾病。
Expert Rev Cardiovasc Ther. 2010 Dec;8(12):1777-801. doi: 10.1586/erc.10.125. Epub 2010 Aug 16.
4
New antiobesity agents: lorcaserin (Belviq) and phentermine/topiramate ER (Qsymia).新型减肥药：lorcaserin（Belviq）和 phentermine/topiramate ER（Qsymia）。
Cardiol Rev. 2014 Jan-Feb;22(1):43-50. doi: 10.1097/CRD.0000000000000001.
5
[A drug help in reducing? Risk profile decides whether and how].[一种药物有助于降低？风险状况决定是否以及如何]。
这段原文似乎不太完整和清晰，翻译出来的内容也有些费解。
MMW Fortschr Med. 2003 May 22;145(21):60.
6
A comparative trial of different regimens of fenfluramine and phentermine in obesity.
Practitioner. 1973 Aug;211(262):232-6.
7
New agent for obesity management.
J Fam Pract. 1996 Sep;43(3):224; author reply 225.
8
Phentermine/topiramate for weight reduction and treatment of adverse metabolic consequences in obesity.苯丁胺/托吡酯用于减肥及治疗肥胖相关的不良代谢后果。
Drugs Today (Barc). 2011 Dec;47(12):903-14. doi: 10.1358/dot.2011.47.12.1718738.
9
Pharmacological therapies for obesity.肥胖的药物治疗
Gastroenterol Clin North Am. 2005 Mar;34(1):91-104. doi: 10.1016/j.gtc.2004.12.002.
10
Medications for weight reduction.减肥药物。
Med Clin North Am. 2011 Sep;95(5):989-1008. doi: 10.1016/j.mcna.2011.06.009.
Zotero 插件